Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

A new warning for healthcare workers receiving a COVID-19 vaccine | Sacubitril/valsartan for HFpEF patients

News You Need to Know Today
A new warning for healthcare workers receiving a COVID-19 vaccine | Sacubitril/valsartan for HFpEF patients
Tuesday, February 2, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CDC shares a new warning for healthcare workers receiving a COVID-19 vaccine

Healthcare workers should pay close attention to any symptoms they experience after receiving a COVID-19 vaccine, according to a new analysis.

READ MORE >
Covid Vaccine
Share on Twitter Share on Facebook Share on Linkedin

CDC shares a new warning for healthcare workers receiving a COVID-19 vaccine

Share on Twitter Share on Facebook Share on Linkedin
Covid Vaccine
Healthcare workers should pay close attention to any symptoms they experience after receiving a COVID-19 vaccine, according to a new analysis.
READ MORE >

Sacubitril/valsartan improves self-reported quality of life for HFpEF patients

However, treatment with sacubitril/valsartan did not lead to improvements in hospitalizations for heart failure or all-cause mortality.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Sacubitril/valsartan improves self-reported quality of life for HFpEF patients

Share on Twitter Share on Facebook Share on Linkedin
However, treatment with sacubitril/valsartan did not lead to improvements in hospitalizations for heart failure or all-cause mortality.
READ MORE >

Edwards shares ‘encouraging’ 5-year data on RESILIA tissue aortic valve

According to new data from the ongoing COMMENCE clinical trial, patients showed no signs of structural valve deterioration after five years.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Edwards shares ‘encouraging’ 5-year data on RESILIA tissue aortic valve

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
According to new data from the ongoing COMMENCE clinical trial, patients showed no signs of structural valve deterioration after five years.
READ MORE >

Medtronic’s new AFib ablation system gains FDA approval

The system sends real-time feedback to healthcare providers during the treatment process. 

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s new AFib ablation system gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The system sends real-time feedback to healthcare providers during the treatment process. 
READ MORE >

Featured Articles

AI model IDs high-risk cardiovascular patients based on imaging data

The algorithm can help physicians make key decisions about a patient’s health, including whether or not it is time to consider statin therapy. 

READ MORE >
Artificial intelligence (AI) has been one of the biggest stories in healthcare for years, but many clinicians still remain unsure about how, exactly, they should be using AI to help their patients. A new analysis in European Heart Journal explored that exact issue, providing cardiology professionals with a step-by-step breakdown of how to get the most out of this potentially game-changing technology.
Share on Twitter Share on Facebook Share on Linkedin

AI model IDs high-risk cardiovascular patients based on imaging data

Share on Twitter Share on Facebook Share on Linkedin
Artificial intelligence (AI) has been one of the biggest stories in healthcare for years, but many clinicians still remain unsure about how, exactly, they should be using AI to help their patients. A new analysis in European Heart Journal explored that exact issue, providing cardiology professionals with a step-by-step breakdown of how to get the most out of this potentially game-changing technology.
The algorithm can help physicians make key decisions about a patient’s health, including whether or not it is time to consider statin therapy. 
READ MORE >

FDA announces yet another new recall for extended-release metformin due to contamination

This is the second voluntary recall for extended-release metformin of 2021. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA announces yet another new recall for extended-release metformin due to contamination

Share on Twitter Share on Facebook Share on Linkedin
This is the second voluntary recall for extended-release metformin of 2021. 
READ MORE >

Healthcare groups warn against ‘triple threat’ of air pollution, cardiovascular disease and COVID-19

The American College of Cardiology, American Heart Association, European Society of Cardiology and World Heart Federation all collaborated on a new joint statement.

READ MORE >
Smog
Share on Twitter Share on Facebook Share on Linkedin

Healthcare groups warn against ‘triple threat’ of air pollution, cardiovascular disease and COVID-19

Share on Twitter Share on Facebook Share on Linkedin
Smog
The American College of Cardiology, American Heart Association, European Society of Cardiology and World Heart Federation all collaborated on a new joint statement.
READ MORE >

From the Magazine

ENJOY THE GLIDE More Retirement Glide-paths Means Wins for Everyone

Some cardiologists vow to go out with their scrubs on, says St. Vincent Heart Center’s Mary Norine Walsh, MD, as she recalls an interventional cardiologist who declared that when he left the cath lab, he’d be gone for good, not doing “office work.”

READ MORE >
Enjoy The Glide
Share on Twitter Share on Facebook Share on Linkedin

ENJOY THE GLIDE More Retirement Glide-paths Means Wins for Everyone

Share on Twitter Share on Facebook Share on Linkedin
Enjoy The Glide
Some cardiologists vow to go out with their scrubs on, says St. Vincent Heart Center’s Mary Norine Walsh, MD, as she recalls an interventional cardiologist who declared that when he left the cath lab, he’d be gone for good, not doing “office work.”
READ MORE >

In Other News

Consumers want a better way to pay for healthcare

To retain current patients, healthcare providers are rolling out new technologies like virtual care and digital payment processes. 

READ MORE >
Researchers found millions of heart failure patients who qualify for standard, guideline directed medical therapies, but did not receive it due to poor health literacy, limited access to care and medication costs.
Share on Twitter Share on Facebook Share on Linkedin

Consumers want a better way to pay for healthcare

Share on Twitter Share on Facebook Share on Linkedin
Researchers found millions of heart failure patients who qualify for standard, guideline directed medical therapies, but did not receive it due to poor health literacy, limited access to care and medication costs.
To retain current patients, healthcare providers are rolling out new technologies like virtual care and digital payment processes. 
READ MORE >

US drug prices soar above international averages

Drug prices in the U.S. are significantly higher than those in peer countries, according to new research from RAND. In fact, compared with 32 other countries combined, drug prices in the U.S. are 256% higher.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

US drug prices soar above international averages

Share on Twitter Share on Facebook Share on Linkedin
Drug prices in the U.S. are significantly higher than those in peer countries, according to new research from RAND. In fact, compared with 32 other countries combined, drug prices in the U.S. are 256% higher.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The latest on PFA risks | EP catheters recalled | Doctors exempt from work visa freeze | Good news for Heartflow
Top 10 most popular cardiology video interviews this past month
Week in Review: New IVL data | TAVR trend prompts 'call to action' | Compensation climbs | Ablations in ASCs | More recalls
News Alert: Thousands of reprocessed EP catheters recalled
New heart failure device impresses | Cardiac amyloidosis in the spotlight | Experts agree: HFmrEF should not be ignored
Cardiology salaries outpace other specialties | A new TAVR technique | Cardiac amyloidosis in the spotlight | BP drug recalled
A new device warning after 3 deaths | AI predicts stroke risk | FDA clears intravascular imaging tech | IV fluids recalled

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Page 4
    • Current page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme